Compounds > glycine
Page last updated: 2024-10-18

glycine and Rheumatic Diseases

glycine has been researched along with Rheumatic Diseases in 5 studies

Rheumatic Diseases: Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement.

Research Excerpts

ExcerptRelevanceReference
" The highest dosage employed (1800 mg/die) performs an excellent therapeutical activity which is equivalent to that at the 1200 mg in reducing pain symptomatology, but on the average less tolerated."2.67[A clinical study to determine the optimal dosage of ST-679 in the treatment of rheumatic diseases]. ( Donati, G; Spinazzè, R, 1993)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
COSTA, E1
FERRARI, W1
SCHIAVETTI, A1
Donati, G1
Spinazzè, R1
Guerzoni, PL1
Chalabi, G1

Trials

2 trials available for glycine and Rheumatic Diseases

ArticleYear
[A clinical study to determine the optimal dosage of ST-679 in the treatment of rheumatic diseases].
    La Clinica terapeutica, 1993, Volume: 142, Issue:1 Pt 2

    Topics: Acute Disease; Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chi-Square Dist

1993
[Experiences in the therapeutic efficacy of a combined preparation for the treatment of joint disorders of degenerative and rheumatic type].
    La Clinica terapeutica, 1975, Apr-30, Volume: 73, Issue:2

    Topics: Acetanilides; Adult; Aged; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Female; Gly

1975

Other Studies

3 other studies available for glycine and Rheumatic Diseases

ArticleYear
[Capacity of glycine to sensitize the adrenal cortex toward antirheumatic drugs].
    Archives internationales de pharmacodynamie et de therapie, 1955, Nov-01, Volume: 104, Issue:1

    Topics: Adrenal Cortex; Analgesics; Antirheumatic Agents; Fabaceae; Glycine; Glycine Agents; Humans; Nervous

1955
[Combined mephenesin-salicylamide in the treatment of rheumatic disease].
    Il Policlinico. Sezione pratica, 1958, Jun-16, Volume: 65, Issue:24

    Topics: Antacids; Fabaceae; Glycine; Mephenesin; Rheumatic Diseases; Salicylamides

1958
[Stosstherapy with steroid-containing combination preparation "Ambene" in the acute stages of rheumatic diseases].
    MMW, Munchener medizinische Wochenschrift, 1975, Mar-07, Volume: 117, Issue:10

    Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aluminum; Aminopyrine; Anti-Inflammato

1975